【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Predictive Genetic Testing & Consumer/Wellness Genomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Rise in number of novel partnership models
3.1.1.2 Introduction of fragmented point-solutions across the genomics value chain
3.1.1.3 Exponentially decreasing costs for genetic sequencing
3.1.1.4 Introduction of technological advancements in cloud computing and data integration
3.1.2 Market Restraint Analysis
3.1.2.1 Absence of well-defined regulatory framework and low adoption rate
3.1.2.2 Ethical concerns pertaining to implementation
3.2 Penetration & Growth Prospect Mapping for Applications, 2015
3.3 Predictive genetic testing & consumer/wellness genomics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Type Estimates & Trend Analysis
4.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Types Movement Analysis
4.2 Predictive Testing
4.2.1 Global predictive testing market, 2013 – 2025 (USD Million)
4.2.2 Genetic susceptibility test
4.2.2.1 Global genetic susceptibility test market, 2013 – 2025 (USD Million)
4.2.3 Predictive diagnostics
4.2.3.1 Global predictive diagnostics test market, 2013 – 2025 (USD Million)
4.2.4 Population screening programs
4.2.4.1 Global population screening programs market, 2013 – 2025 (USD Million)
4.3 Consumer Genomics
4.3.1 Global consumer genomics market, 2013 – 2025 (USD Million)
4.4 Wellness Genetics
4.4.1 Global wellness genetics market, 2013 – 2025 (USD Million)
4.4.2 Nutria Genetics
4.4.2.1 Global nutria genetics market, 2013 – 2025 (USD Million)
4.4.3 Skin & Metabolism Genetics
4.4.3.1 Global skin & metabolism genetics market, 2013 – 2025 (USD Million)
4.4.4 Others
4.4.4.1 Global others market, 2013 – 2025 (USD Million)
Chapter 5 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Estimates & Trend Analysis
5.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Movement Analysis
5.2 Breast & Ovarian Cancer Screening
5.2.1 Global breast & ovarian cancer screening market, 2013 – 2025 (USD Million)
5.3 Cardiovascular Screening
5.3.1 Global cardiovascular screening market, 2013 – 2025 (USD Million)
5.4 Diabetic Screening & Monitoring
5.4.1 Global diabetic screening & monitoring market, 2013 – 2025 (USD Million)
5.5 Colon Cancer Screening
5.5.1 Global colon cancer screening market, 2013 – 2025 (USD Million)
5.6 Parkinsonism / Alzheimer’s disease
5.6.1 Global Parkinsonism / Alzheimer’s disease market, 2013 – 2025 (USD Million)
5.7 Urologic Screening/ Prostate Cancer Screening
5.7.1 Global urologic screening/ prostate cancer screening market, 2013 – 2025 (USD Million)
5.8 Orthopedic & Musculoskeletal Screening
5.8.1 Global orthopedic & musculoskeletal screening market, 2013 – 2025 (USD Million)
5.9 Other Cancer Screening
5.9.1 Global other cancer screening market, 2013 – 2025 (USD Million)
5.10 Other Diseases Screening
5.10.2 Global other diseases screening market, 2013 – 2025 (USD Million)
Chapter 6 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Regional Estimates & Trend Analysis, by Test Type & Application
6.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3 Europe
6.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.3 UK
6.3.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.3 China
6.4.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.4 Australia
6.4.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.5 India
6.4.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.6 Singapore
6.4.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5 Latin America
6.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6 MEA
6.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.2.1 Key Initiatives
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd
7.3.1.1 Company overview
7.3.1.1.1 454 Life Sciences (Roche Diagnostics Corporation)
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Abbott (Abbott Diagnostics)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Thermo Fisher Scientific, Inc.
7.3.3.1 Company overview
7.3.3.1.1 Affymetrix, Inc.
7.3.3.1.2 Applied Biosystems
7.3.3.2 Financial performance
7.3.3.2.1 Financial performance (Affymetrix)
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Agilent Technologies
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 BGI
7.3.5.1 Company overview
7.3.5.1.1 Complete Genomics Incorporated
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Bio-Rad Laboratories, Inc.
7.3.6.1 Company overview
7.3.6.1.1 GnuBIO, Inc.
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Illumina, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 QIAGEN
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Alere
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Myriad Genetics, Inc.
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Siemens Healthineers
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Pathway Genomics
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Cooper Surgical, Inc.
7.3.13.1 Company overview
7.3.13.1.1 Genesis Genetics
7.3.13.1.2 Reprogenetics
7.3.13.1.3 Financial performance
7.3.13.1.4 Financial performance
7.3.13.2 Product benchmarking
7.3.13.3 Strategic initiatives
7.3.14 Ambry Genetics Corporation
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 23andMe, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Danaher
7.3.16.1 Company overview
7.3.16.1.1 Beckman Coulter, Inc.
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 Cepheid
7.3.17.1 Company overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
7.3.18 Hologic, Inc. (Gen-Probe Incorporated)
7.3.18.1 Company overview
7.3.18.2 Financial performance
7.3.18.3 Product benchmarking
7.3.18.4 Strategic initiatives
7.3.19 ARUP Laboratories
7.3.19.1 Company overview
7.3.19.2 Financial performance
7.3.19.3 Product benchmarking
7.3.19.4 Strategic initiatives
7.3.20 GUARDANT HEALTH, INC
7.3.20.1 Company overview
7.3.20.2 Financial performance
7.3.20.3 Product benchmarking
7.3.20.4 Strategic initiatives
7.3.21 Advanced Genomic Solutions (AGS) Ltd
7.3.21.1 Company overview
7.3.21.2 Financial performance
7.3.21.3 Product benchmarking
7.3.21.4 Strategic initiatives
7.3.22 EasyDNA
7.3.22.1 Company overview
7.3.22.2 Financial performance
7.3.22.3 Product benchmarking
7.3.22.4 Strategic initiatives
7.3.23 Color Genomics, Inc.
7.3.23.1 Company overview
7.3.23.2 Financial performance
7.3.23.3 Product benchmarking
7.3.23.4 Strategic initiatives
7.3.24 Counsyl, Inc.
7.3.24.1 Company overview
7.3.24.2 Financial performance
7.3.24.3 Product benchmarking
7.3.24.4 Strategic initiatives
7.3.25 Gene by Gene
7.3.25.1 Company overview
7.3.25.2 Financial performance
7.3.25.3 Product benchmarking
7.3.26 Mapmygenome
7.3.26.1 Company overview
7.3.26.2 Financial performance
7.3.26.3 Product benchmarking
7.3.26.4 Strategic initiatives
7.3.27 Interleukin Genetics Inc.
7.3.27.1 Company overview
7.3.27.2 Financial performance
7.3.27.3 Product benchmarking
7.3.27.4 Strategic initiatives
7.3.28 Laboratory Corporation of America Holdings (LabCorp)
7.3.28.1 Company overview
7.3.28.2 Financial performance
7.3.28.3 Product benchmarking
7.3.28.4 Strategic initiatives
7.3.29 Quest Diagnostics Incorporated
7.3.29.1 Company overview
7.3.29.1.1 Sonora Quest Laboratories
7.3.29.2 Financial performance
7.3.29.2.1 Financial performance
7.3.29.3 Product benchmarking
7.3.29.4 Strategic initiatives
7.3.30 Xcode
7.3.30.1 Company overview
7.3.30.2 Financial performance
7.3.30.3 Product benchmarking
7.3.30.4 Strategic initiatives
7.3.31 Amgen, Inc.
7.3.31.1 Company overview
7.3.31.1.1 deCODE genetics
7.3.31.2 Financial performance (Amgen, Inc.)
7.3.31.3 Product benchmarking
【レポート販売概要】
■ タイトル：予測遺伝子検査と消費者/ウェルネスゲノミクスの世界市場分析：用途別（がん、糖尿病のスクリーニング、パーキンソン病、循環器、整形外科･筋骨格系、ヌートリア遺伝学、皮膚･代謝遺伝学）、動向分析、2013-2025■ 英文：Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics), And Trend Analysis From 2013 To 2025
■ 発行日：2017年1月27日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707698
■ 調査対象地域：グローバル
- 自動車用複合材料の世界市場：高分子基複合材料、金属基複合材料、セラミックス基複合材料Composites have found wide acceptance in various industries including automotive because of their light weight and environmental resistance characteristics. On the basis of application areas, the market of automotive composite can be broadly segmented into interior, exterior, chassis & powertrain components and others. Though exterior components is the major application of automotive composite, ch …
- 子宮頸がん診断検査の世界市場2016-2020About Cervical Cancer Diagnostic Testing The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages when they can be treated easily. In the US, National Breast and …
- Hepatic (Liver) Tumor：グローバル臨床試験レビューH2, 2013Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hepatic (Liver) Tumor Global Clinical Trials Review, H2, 2013" provides data on the Hepatic (Liver) Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic (Liver) Tumor. It includes an overview of the trial numbers and the …
- 世界の殺線虫剤市場2015The Global Nematicides Industry Report 2015 is a professional and in-depth study on the current state of the Nematicides industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Nematicides market analysis is provided for the international markets including development trends, competitive landscape analysis …
- ビデオ監視の世界市場予測（～2022）：システム（アナログ、IP、バイオメトリクス）、機器（カメラ、モニタ、ストレージデバイス）、ソフトウェア、サービスThe video surveillance market is projected to reach USD 75.64 Billion by 2022, at a CAGR of 15.4% between 2017 and 2022. The growth of this market can be attributed to the increasing demand for IP cameras, owing to their better functionality and reduced cost, use of cloud services to store large amounts of data, and increasing installation of surveillance systems for security reasons. Based on har …
- デジタルMROの世界市場予測（～2030年）Increasing demand for unmanned vehicles and ongoing military modernization programs are expected to fuel the growth of the digital MRO market across the globe.The digital MRO market is projected to grow from USD 1.0 billion in 2019 to USD 4.7 billion by 2030, at a CAGR of 14.6% from 2019 to 2030. Increasing digitalization of MRO to increase efficiency and reduce aircraft downtime is the key factor …
- 交通分野における人工知能（AI）の世界市場予測（～2030年）：ディープラーニング、コンピュータビジョン、コンテキストアウェアネス、NLPThe artificial intelligence in transportation market is projected to grow at a CAGR of 17.87% from 2017 to 2030, and the market size is expected to grow from USD 1.21 Billion in 2017 to USD 10.30 Billion by 2030. The increasing government regulations for vehicle safety, growing adoption of advanced driver assistance systems (ADAS), and development of autonomous vehicles play a significant role in …
- 後処理プロセスの世界市場予測（～2021）：クロマトグラフィーカラム・樹脂、フィルター、シングルユースThe global downstream processing market is projected to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021. In this report, the global market is broadly segmented on the basis of technique, product, application, end user, and region. Major factors driving the growth of the market are increasing R&D expenditure in the biopharmaceutical industry and …
- 自動車用シリコーンの世界市場：製品別（ゴム、コーティング剤、接着剤・シーラント剤）、用途別（電気、サスペンション、EDTシステム、内装・外装）、セグメント予測The global automotive silicone market size is expected to reach USD 9.47 billion by 2025 growing at a CAGR of 6.4% over the forecast period, according to a new report by Grand View Research, Inc. Growing production of automobiles, especially lightweight vehicles, and stringent regulations pertaining to harmful emissions are the driving factors for the market. Silicones help reduce the overall vehi …
- Questar Corporation：石油・ガスバリューチェーン分析レポート2013Questar Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Questar Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Questar Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- 世界のポリマーコーティング生地市場：製品別（ポリビニル、ポリウレタン、ポリエチレン）、用途別（輸送、防護服、工業用、日除け、屋根＆天蓋、家具＆座席）、地域別“Rising safety measures in transportation application.” The polymer coated fabrics market is estimated to be USD 16.3 billion in 2019 and is projected to reach USD 20.1 billion by 2024, at a CAGR of 4.3% between 2019 and 2024. The rising safety measures in the transportation application and the stringent regulatory requirements for workers’ safety are expected to drive the coated fabrics market. H …
- TCMS（列車制御・管理システム）の世界市場予測（～2021年）：車両制御ユニット、モバイル通信ゲートウェイ、HMIThe global Train Control And Management System (TCMS) Market is projected to grow at a CAGR of 7.72% from 2016 to 2021, to reach a market size of USD 3.28 Billion by 2021. The growing inclination towards rapid, safe, and comfortable transport, increasing urbanization, and stringent emission norms have fueled the growth of the TCMS market. The North American TCMS market is projected to grow at the …
- 肉代替食品（大豆、小麦、マイコプロテイン）のグローバル市場（～2019）Owing to the rise in living standards, rising health awareness, outbreak of animal disease, and ethics, that is, not to kill the animals or the concern towards the animals are driving the people to be vegetarian, which in turn is fuelling the demand for the meat substitutes market. This report estimates the market value of types of meat substitutes, their sources, and categories. In terms of geogr …
- 世界のナノ技術市場動向：ナノ材料、ナノツール、ナノデバイスNanotechnology is a growing interdisciplinary technology that is often seen as a new industrial revolution. Nanotechnology is increasingly attracting worldwide attention owing to its wide range of end-uses. As nanotechnology is evolving, so is the scope for its commercial expansion. The wide range of potential products and applications gives nanotechnology its enormous growth prospects. It has bee …
- 疼痛（Pain）治療薬の世界市場：画期的医薬品の市場機会及び商用化Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation Summary Large and Innovative Pipeline The active pain pipeline is populated by 796 products across all stages of development, which exhibit a highly diverse range of molecular targets. GBI Research’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting o …
